Acorah Software Products - Accounts Production 16.1.300 false true false true No description of principal activity 15 June 2023 30 June 2024 30 June 2024 14937988 Mr Benjamin Bassaly iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14937988 2023-06-14 14937988 2024-06-30 14937988 2023-06-15 2024-06-30 14937988 frs-core:CurrentFinancialInstruments 2024-06-30 14937988 frs-bus:PrivateLimitedCompanyLtd 2023-06-15 2024-06-30 14937988 frs-bus:FilletedAccounts 2023-06-15 2024-06-30 14937988 frs-bus:Micro-entities 2023-06-15 2024-06-30 14937988 frs-bus:AuditExempt-NoAccountantsReport 2023-06-15 2024-06-30 14937988 frs-bus:Director1 2023-06-15 2024-06-30
Registered number: 14937988
Advanced Clinical Consulting Ltd
Unaudited Financial Statements
For the Period 15 June 2023 to 30 June 2024
Balance Sheet
Registered number: 14937988
30 June 2024
£
Fixed assets 642
Current assets 10,516
Creditors: Amounts Falling Due Within One Year (4,284 )
NET CURRENT ASSETS 6,232
TOTAL ASSETS LESS CURRENT LIABILITIES 6,874
Accruals and deferred income (299 )
NET ASSETS 6,575
CAPITAL AND RESERVES 6,575

Notes

1. General Information
Advanced Clinical Consulting Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14937988 . The registered office is 14 Parkfield Road, Ickenham, Uxbridge, UB10 8LN.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Benjamin Bassaly
Director
4th March 2025